News
15 March 2021
BAP Pharma rank 78th in the Minority Supplier Development UK Report 2021
We are excited and proud to announce that BAP Pharma have ranked 78th in the Minority Supplier Development UK Report 2021 – the first ever list of the country’s top 100 minority businesses.
The Minority Supplier Development UK (MSDUK) is the UK’s premier not-for-profit membership organisation, championing diversity and inclusion in the public and private sector supply chains.
MSDUK collaborated with OPEN to produce exclusive new research and analysis, to develop the Minority Businesses Matter report, which highlights the importance and untapped potential of ethnic minority businesses.
This landmark report aims to bring change to minority businesses contributions being overlooked by policymakers and the wider business community, by presenting fresh analysis of existing evidence on minority businesses.
Despite the challenges often faced, ethnic-minority entrepreneurs and businesses make a huge economic contribution to the UK, with minority businesses contributing at least £74 billion a year to the UK economy.
In 2019-20, minority businesses contributed gross value added of at least £74 billion, £47.9 billion in employee compensation, £4.7 billion in corporation tax payments and £21.4 billion in post-tax profits.
“We are extremely proud to be recognised in the first ever list of the country’s top 100 minority businesses, for our efforts to champion diversification within BAP Pharma. This would not have been possible without the support from our clients, who recognise diversity as an essential part of their culture and our diverse workforce”.
Dr. Bashir Pakar, Founder and Managing Director of BAP Pharma.
BAP Pharma’s rankings in the Minority Supplier Development UK Report 2021:
Ranked 78th in The MSDUK-OPEN Top 100 Minority Businesses 2019-20
Ranked 9th in the Top 10 Minority Businesses with the Highest Foreign Sales as a percentage of turnover 2019-20
Ranked 8th in the Top 10 Minority Pharmaceutical Business by turnover 2019-20
You Might Also Like

BAP Pharma ranked in FEBE Growth 100 List
BAP Pharma are honoured to receive an award from FEBE Growth 100 and to have been ranked within the 2022 list of the fastest growing, founder-led, privately-owned UK businesses. BAP Pharma receiving the FEBE Growth 100 Award – pictured left to right – Award Partner Anthony Higson from Pictet, FEBE
Read More
BAP Pharma awarded Thames Valley 250 Special Recognition Award
BAP Pharma are the proud recipients of the Thames Valley 250 Special Recognition Award. The Thames Valley 250 Special Recognition Award is presented to a company that has shown outstanding achievement, innovation and commitment, while significantly contributing to the Thames Valley economy and the wider community. In 2020, BAP Pharma
Read More
BAP Pharma awarded EcoVadis Silver Sustainability Rating
BAP Pharma are excited and proud to announce that we have achieved a Silver rating in the recent EcoVadis Sustainability ratings, placing the company within the 90th percentile of all rated companies worldwide. EcoVadis review more than 75,000 companies based on four main areas: Environment Labour & Human Rights Ethics
Read More